Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites

被引:0
|
作者
Shen Chen
Yiqiao Jiao
Yiyang Han
Jie Zhang
Yuanyuan Deng
Zilu Yu
Jiao Wang
Shasha He
Wei Cai
Jixiong Xu
机构
[1] First Affiliated Hospital of Nanchang University,Department of Endocrinology and Metabolism
[2] Jiangxi Clinical Research Center for Endocrine and Metabolic Disease,Queen Mary School, Medical College
[3] Jiangxi Branch of National Clinical Research Center for Metabolic Disease,Department of Medical Genetics and Cell Biology
[4] Nanchang University,undefined
[5] Medical College of Nanchang University,undefined
来源
Acta Diabetologica | 2024年 / 61卷
关键词
T2DM; Edible traditional Chinese medicines; Gut microbiotal metabolites; Short-chain fatty acids; Bile acids; Branched-chain amino acids;
D O I
暂无
中图分类号
学科分类号
摘要
Type 2 diabetes mellitus (T2DM) is a metabolic disorder with intricate pathogenic mechanisms. Despite the availability of various oral medications for controlling the condition, reports of poor glycemic control in type 2 diabetes persist, possibly involving unknown pathogenic mechanisms. In recent years, the gut microbiota have emerged as a highly promising target for T2DM treatment, with the metabolites produced by gut microbiota serving as crucial intermediaries connecting gut microbiota and strongly related to T2DM. Increasingly, traditional Chinese medicine is being considered to target the gut microbiota for T2DM treatment, and many of them are edible. In studies conducted on animal models, edible traditional Chinese medicine have been shown to primarily alter three significant gut microbiotal metabolites: short-chain fatty acids, bile acids, and branched-chain amino acids. These metabolites play crucial roles in alleviating T2DM by improving glucose metabolism and reducing inflammation. This review primarily summarizes twelve edible traditional Chinese medicines that improve T2DM by modulating the aforementioned three gut microbiotal metabolites, along with potential underlying molecular mechanisms, and also incorporation of edible traditional Chinese medicines into the diets of T2DM patients and combined use with probiotics for treating T2DM are discussed.
引用
收藏
页码:393 / 411
页数:18
相关论文
共 50 条
  • [31] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    Cunningham, A. L.
    Stephens, J. W.
    Harris, D. A.
    GUT PATHOGENS, 2021, 13 (01)
  • [32] The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats
    Yongcheng An
    Hongyu Dai
    Yuhui Duan
    Long Cheng
    Lu Shi
    Changhao He
    Chen Wang
    Yinglan Lv
    Huimin Li
    Huilin Zhang
    Yan Huang
    Wanxin Fu
    Weiguang Sun
    Baosheng Zhao
    Chinese Medicine, 18
  • [33] The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
    Kootte, R. S.
    Vrieze, A.
    Holleman, F.
    Dallinga-Thie, G. M.
    Zoetendal, E. G.
    de Vos, W. M.
    Groen, A. K.
    Hoekstra, J. B. L.
    Stroes, E. S.
    Nieuwdorp, M.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02) : 112 - 120
  • [34] Portulaca oleracea L. Extract Alleviated Type 2 Diabetes Via Modulating the Gut Microbiota and Serum Branched-Chain Amino Acid Metabolism
    Bao, Meili
    Hou, Kexin
    Xin, Chao
    Zeng, Deyong
    Cheng, Cuilin
    Zhao, Haitian
    Wang, Zhenyu
    Wang, Lu
    MOLECULAR NUTRITION & FOOD RESEARCH, 2022, 66 (11)
  • [35] Exopolysaccharide from Leuconostoc pseudomesenteroides XG5 delay the onset of autoimmune diabetes by modulating gut microbiota and its metabolites SCFAs in NOD mice
    Pan, Lei
    Zhou, Zhijiang
    Han, Ye
    JOURNAL OF FUNCTIONAL FOODS, 2021, 79
  • [36] The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats
    An, Yongcheng
    Dai, Hongyu
    Duan, Yuhui
    Cheng, Long
    Shi, Lu
    He, Changhao
    Wang, Chen
    Lv, Yinglan
    Li, Huimin
    Zhang, Huilin
    Huang, Yan
    Fu, Wanxin
    Sun, Weiguang
    Zhao, Baosheng
    CHINESE MEDICINE, 2023, 18 (01)
  • [37] Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus
    He, Liying
    Yang, Fang-Qing
    Tang, Pan
    Gao, Ting-Hui
    Yang, Cai-Xia
    Tan, Li
    Yue, Pan
    Hua, Ya-Nan
    Liu, Si-Jing
    Guo, Jin-Lin
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [38] Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
    Duan, Liyun
    An, Xuedong
    Zhang, Yuehong
    Jin, De
    Zhao, Shenghui
    Zhou, Rongrong
    Duan, Yingying
    Zhang, Yuqing
    Liu, Xinmin
    Lian, Fengmei
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [39] Associations of dietary diversity with the gut microbiome, fecal metabolites, and host metabolism: results from 2 prospective Chinese cohorts
    Xiao, Congmei
    Wang, Jia-ting
    Su, Chang
    Miao, Zelei
    Tang, Jun
    Ouyang, Yifei
    Yan, Yan
    Jiang, Zengliang
    Fu, Yuanqing
    Shuai, Menglei
    Gou, Wanglong
    Xu, Fengzhe
    Yu, Evan Y-W
    Liang, Yuhui
    Liang, Xinxiu
    Tian, Yunyi
    Wang, Jiali
    Huang, Feifei
    Zhang, Bing
    Wang, Huijun
    Chen, Yu-ming
    Zheng, Ju-Sheng
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2022, 116 (04) : 1049 - 1058
  • [40] Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus
    Yang Yong
    Han Zihan
    Gao Zhaoya
    Chen Jiajia
    Song Can
    Xu Jingxuan
    Wang Hanyang
    Huang An
    Shi Jingyi
    Gu Jin
    中华医学杂志英文版, 2023, 136 (23)